VectorY Therapeutics targets misfolded proteins
Interviewee/Contributor
Alexander Vos and Sander van Deventer
Organisation
VectorY Therapeutics BV
Drug discovery
How faster insulin can enable the artificial pancreas
Interviewee/Contributor
David Gerring
Organisation
Arecor Therapeutics Plc
Revisiting herpes simplex virus leads to invention
Interviewee/Contributor
Gerald Kleymann
Organisation
Innovative Molecules GmbH
Shining a light on the dark genome
Interviewee/Contributor
Danuta Jeziorska
Novel antifungals set for market introduction
Interviewee/Contributor
Peter Charlish
Organisation
MedNous
Live biotherapeutics change the pharma landscape
Interviewee/Contributor
Duncan Peyton
Organisation
4D pharma Plc
ASCO 2021- Oncology developers disclose their latest data
Interviewee/Contributor
Victoria English
Organisation
MedNous
Insect-derived peptides - next generation antibiotics?
Interviewee/Contributor
Moshik Cohen-Kutner and Niv Bachnoff
Organisation
Omnix Medical
Phosphatases rise from the ashes
Interviewee/Contributor
Gerhard Müller
Organisation
Anavo Therapeutics BV
A new strategy for regenerating damaged tissue
Interviewee/Contributor
Tim Knotnerus
Organisation
AgomAb Therapeutics NV